Return to study ST000388 main page
MB Sample ID: SA018158
Local Sample ID: | LungNodule_45 |
Subject ID: | SU000409 |
Subject Type: | Human |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Age Or Age Range: | 53-81 |
Gender: | Male/Female |
Human Smoking Status: | Former/Current |
Species Group: | Human |
Select appropriate tab below to view additional metadata details:
Treatment:
Treatment ID: | TR000423 |
Treatment Summary: | The NYU Lung Cancer Biomarker Center performs low-dose CT-scan screening for high-risk smokers as part of the National Cancer Institute’s Early Detection Research Network Program (EDRN). Lung cancer cases for this study were confirmed by pathology (Table 1). Patients with benign nodules were those with stable nodules or ground glass opacity (GGO) over at least two year period with annual CT scans performed. Post-diagnosis samples were collected at least one month post-surgery. Selection of cases was performed by NYU and the blinded serum samples were sent to University of California, Davis Medical Center (UCDMC) for analysis. None of the study subjects had previous cancer or chemotherapy. All subjects had blood drawn by EDRN protocol, performed spirometry according to ATS guidelines,and answered questionnaires with smoking and occupational history. |